Author

Smiths Lueong

Deutsches Konsortium für Translationale KrebsforschungORCID 0000-0002-2776-6706Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Smiths S. Lueong1 paper · German Cancer Research Center

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:protein folding & dynamics· 1 Assay:proteomics· 1

Frequent Co-Authors

Annette PascheniD· 2 shared Farnusch KaschaniiD· 2 shared Jens Thomas SivekeiD· 2 shared A. Hoewner· 1 shared Alexander RoeschiD· 1 shared Alpaslan TasdoganiD· 1 shared Barbara T. GrünwaldiD· 1 shared Batool Shannan· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMolecular Biology

Annette PaschenORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Molecular BiologybioRxivPreprintNov 12, 2026

A role for TRIP12 in regulating the E3 ligase network under proteotoxic stress

Hai Trinh, Farnusch Kaschani, Markus Kaiser…·Michael Ehrmann

This study identifies TRIP12 as a proteostasis-responsive E3 ligase that regulates protein stability and the proteostasis network under proteotoxic stress.

DOI 10.64898/2026.11.10.764862

humanproteomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintMar 10, 2025

Redirecting resistance evolution in BRAFV600 melanoma by inhibition of the peroxiredoxin-thioredoxin system

Stefanie Egetemaier, Heike Chauvistré, Renáta Váraljai…·Alexander Roesch

This study identifies KDM5B's role in regulating the PRDX/TXN ROS detoxification system in melanoma DTPs, showing that PRDX inhibition increases ROS vulnerability and delays resistance to MAPK inhibition.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky